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Summary To determine the optimal surgical therapy for patients with pedunculated hepatocellular carcinoma
(HC), we evaluated findings in ten patients with pedunculated HC among 350 patients with HC who
underwent hepatectomy from 1975 to 1991 at Kyushu University Hospital. These patients were classified into
three groups: Group I (n = 4) Pedunculated HC with no intrahepatic HC, Group II (n = 2) Pedunculated HC
with a single intrahepatic HC, and Group III (n =4) Pedunculated HC with multiple intrahepatic HC.
Patients in group I and II were treated by partial hepatic resections or subsegmentectomies. In two patients
there was an intrahepatic recurrence in the same lobe, after radical resection. All patients in group III who
underwent palliative resection died within 8 months after surgery. Retrospectively, we favour the view that
patients in Groups I or II may have had a better prognosis iflobectomy rather than partial hepatectomies had
been done.
The preoperative diagnosis of pedunculated hepatocellular
carcinoma (HC) was difficult a few years ago (Anthony &
James, 1987; Cunningham et al., 1984; Horie et al., 1983),
but with advances in diagnostics such as ultrasound (US),
computed tomography (CT) and angiography, a preoperative
diagnosis is now feasible (Moritz et al., 1988). From the
review of Moritz et al. (Moritz et al., 1988), surgically treated
patients with pedunculated HC usually died of metastatic
disease, whereas most medically treated patients died of
gastrointestinal or tumour haemorrhage. They concluded
that curative resection was the procedure of choice to pro-
long survival and prevent early death from haemorrhage.
To better determine optimal choice of surgical therapy, we
retrospectively examined our surgical therapy for ten patients
with pedunculated HC.
Patients and methods
Between 1975 and 1991, 350 consecutive patients underwent
hepatic resections for hepatocellular carcinoma at Kyushu
University Hospital, Fukuoka, Japan. Ten of these 350 had
pedunculated HC and we classified these ten into three
groups: Group I, pedunculated HC with no intrahepatic HC
(n = 4). Group II, pedunculated HC with single intrahepatic
HC (n = 2). Group III, pedunculated HC with multiple int-
rahepatic HC (n = 4).
Clinical features, choice of operative procedures and out-
come were evaluated.
Results
Clinicalfeatures
Clinical features of the ten patients with pedunculated HC
are given in Table I. The mean age was 55 years with a range
of 41-72 years, and the male to female ratio was 9:1. Seven
(70%) complained of abdominal pain. Average tumour size
was 7.8 cm in maximum diameter with a range of 4-17 cm.
The pedicle arose from the right hepatic lobe in six, and from
the left lobe in four cases. Hepatitis B surface antigen
(HBsAg) was identified in three cases (30%) and cirrhosis
was present in seven (70%). Using the 20 ng ml-' value as
minimum for positive alpha-fetoprotein (AFP), five cases
(50%) were positive. Histologic classification was done ac-
cording to the grading of Edmondson and Steiner (Edmond-
son & Steiner, 1954). Eight cases (80%) were grade II and/or
III. The correct preoperative diagnosis of pedunculated HC
was made in eight patients (80%). In one patient there was
hepatic rupture (Group II-1) and emergency repair was
needed. The other patient (Group 11-2) had a pedunculated
HC located on the upper surface of the right anterior
superior segment between the liver and the diaphragm.
Surgical treatment and outcome
Group I Figure 1 shows the location and treatment for
patients in group I. Stars show location of the recurrent
tumours. Patients in group I were treated either by
subsegmentectomies or by partial hepatic resections. One
patient had a recurrent tumour in the peritoneal cavity but
no intrahepatic recurrence. The tumour was extirpated and
the patient is alive 37 months after first operation. Two
patients had an intrahepatic recurrence but no evidence of a
distant metastasis. One patient had a recurrence in the same
lobe of the liver and for another patient, recurrence was in
another lobe of the liver. The case 4 patient died 17 months
after surgery. Table II summarises treatment and outcome of
all the patients.
Group II Figure 2 shows the location of the tumours and
the treatment given. Stars show the location of the intra-
hepatic recurrent tumour. The case 1 patient underwent
tumour excision and partial hepatic resection. This patient
had a miliary intrahepatic recurrence 6 years after the first
resection and chemo-embolisation was carried out. Intra-
peritoneal recurrence was also found 6 years and 6 months
after the initial resection. Tumour extirpation was done to
remove obstruction of the intestine. This patient died 7 years
and 6 months after initial resection. The case 2 patient was
treated by partial hepatectomy of the right anterior inferior
segment and the right anterior superior segment. There was a
recurrence in the right posterior inferior segment 13 months
after the hepatectomy.
Group III Figure 3 shows location of the tumours and the
treatment given. All four patients in group III underwent
palliative resection to prevent tumour rupture in three
patients and to control bleeding in one patient. The case 3
patient was treated with left hepatectomy and subtotal gas-
trectomy to control bleeding from the tumour. This patient
died of peritoneal dissemination of HC 3 months after the
resection and all four patients died within 8 months.
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Table I Clinical features ofpedunculated hepatocellular carcinoma
Tumour
Age size Histological
sex Symptoms (cm) Lobe HBsAg LC AFP grade
Group I
1. 63M Abd. pain 17 x 7.5 R (-) (+) 54,160 II-III
2. 41M Free 4 x 3.8 R (+) (+) 5.3 II
x 2.8
3. 72M Abd. pain 5.2 x 5.2 R (-) (-) 6.4 II
x 5.0
4. 53M Abd. 4.9 x 4.0 R (-) (+) 11.6 III
distension
Group II
1. 43M Abd. pain 5.8 x 4.8 L (+) (+) <5 II
x 4.2
2. 59F Abd. pain 4.0 x 3.0 R (-) (+) <5 I
Group III
1. 56M Abd. pain 6.0 x 4.4 L (+) (+) 10,000 II
x 3.5
2. 46M Abd. pain 10 x 10 R (-) (-) 212,660 III
3. 63M Abd. 9.5 x 5.5 L (-) (-) 45,986 III
discomfort x 5.4
4. 54M Abd.pain 12x 11 L (-) (+) 28 III-IV
x 9
LC: livercirrhosis; AFP:alpha-fetoprotein; Abd.:abdominal; M:male; F:female; R:right; L:
left; HBsAg: hepatitis B surface antigen.
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Figure 1 Shown are the shape and location of pedunculated HC. In Group I stars show the location of recurrent HC.
Discussion
Pedunculated HC can mimic other abdominal tumours
(Moritz et al., 1988). Ovarian carcinoma, some of which
demonstrates high levels of AFP (Talerman & Haije, 1974),
may take the form of large masses in the peritoneal cavity.
AFP was positive in five of our ten patients (50%). Gastric
cancer, which may attach to midepigastric structures with
extension into the liver, can resemble pedunculated HC.
After 1970, when celiac angiography became available, a
preoperative diagnosis was feasible and use of CT and US
facilitates a preoperative diagnosis prior to angiography
(Nobusawa et al., 1984; Shimoyama et al., 1986; Kohno et
al., 1987). When US and CT reveal a pedicle of the tumour
and there is a typical pattern of HC, an accurate diagnosis
can be made. When celiac angiography shows a feeder line
from the hepatic artery and a hypervascular mass, a correct
diagnosis is not difficult. In eight out of our ten patients
(80%), a correct diagnosis was made prior to surgery.
From the review of postoperative recurrence of HC,
Nagao et al. (Nagao et al., 1990) suggested that large hepatic
resection for primary tumours was necessary to prevent
recurrence, since most recurrence after partial resection were
observed in the same segment as the primary tumour, or in
one near it. Patients in our group I and II were treated by
partial hepatic resections or subsegmentectomies, two
patients who underwent radical resection had an intrahepatic
recurrence in the same lobe. Thus, intrahepatic recurrencePEDUNCULATED HEPATOCELLULAR CARCINOMA 117
Table II Treatment and outcome ofpedunculated hepatocellular carcinoma
ICG PVP Tumour in Recurrence
Treatment R15% mm saline pedicule fc Rupture -Surgical Tx Survival
Group I
1. S5,6 Subsegmen- 6.6 250 (+) (+) (+) Intraperitoneal (34m) living
tectomy -tumour extirpation 37 m
2. S6 Partial 2.4 200 (+) (+) (-) S5,7 intrahepatic (5 y II m) living
hepatectomy 5 y II m
3. S6 Subsegmen- 13.0 180 (-) (+) (-) S3 introhepatic (4y) living
tectomy -lateral segmentectomy 5 y 8 m
4. S5 Partial 41.9 310 (+) (-) (+) Cancer dissemination died
hepatectomy 17m
Group II
1. Tumour excision 17.7 - (-) (+) (+) Miliary intrahepatic (6 y) died
S2,3 partial Intraperitoneal (6 y 6 m) 7 y 6 m
hepatectomy -tumour extirpation
2. S5,8 partial 18.2 250 (-) (-) (-) S6 intrahepatic died
hepatectomy 13 m
Group III
1. Tumour excision 13.6 260 (-) (-) (-) died
3m
2. Tumour excision 8.2 - (+) (+) (+) died
I m
3. Lt lobectomy 13.1 200 (+) (-) (-) died
gastrectomy 3 m
4. Tumour excision 13.6 185 (+) (+) (-) died
8m
PVP: portalveinpressure;fc: capsule; Tx: treamtne;-: notmeasured; m: month;y: year;S2: theleftlateralsuperiorsegment;
S3: the left lateral inferior segment; S5: the right anterior inferior segment; S6: the left posterior inferior segment; S8: the left
anterior superior segment.
Case 1.Cse2
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Figure 2 Shown are the shape and location of pedunculated HC in Group II. Stars show location of the recurrent HC.
Case 1. Case 2.
Figure 3 Shown are the shape and location of pedunculated HC in Group III.118 T. NISHIZAKI et al.
can probably be avoided if the patients are treated with
lobectomy rather than partial hepatectomies. In our institute,
the indications for hepatic lobectomy for cirrhotic liver are
an indocyanine green retention rate at 15 min (ICG RI5) less
than 20% and a portal vein pressure before hepatectomy less
than 200 mm saline. One of the two patients could have been
treated by right lobectomy in line with these criteria. Even
though liver cirrhosis may limit postoperative functional liver
capacity, a resection would not in most cases be contra-
indicated. The unique localisation of pedunculated HC
allows for a minimal hepatic resection and a chance for a
cure. Three of six patients (50%) survived for over 5 years
after radical surgery.
Despite palliative resection of the tumours and chemo-
embolisation (Kanematsu et al., 1989), all patients in group
III died within 8 months after surgery. Thus, in the absence
of an early diagnosis, radical resection cannot be done.
Kanematsu et al. (Kanematsu et al., 1988) reported that
most recurrences after resection for HC were in the liver, and
that intraperitoneal recurrence was rare. In our study two
patients with pedunculated HC had recurrences in the
peritoneal cavity, and in both, rupture of the tumours was
evident, intraoperatively. With growth of the tumour, the
edge of the pedunculated HC may become ischemic and
fragile. A ruptured HC may lead to an implanted metastasis,
hence, an adequate irrigation of the peritoneal cavity is
recommended after radical resection for pedunculated HC
(Sonoda et al., 1989).
We thank M. Ohara for critical comments.
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